Skip to main content
SpringerLink
Log in

Antimicrobial Resistance: A Global Perspective

  • Chapter
Antimicrobial Resistance

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 390))

Abstract

Antimicrobial resistance is of concern to many of us. However, despite a call for action, we ofttimes seem to be speaking to the wind. As the problem advances, we wonder when and how medical and public health measures will deal with it. Resistance is not local or national, it is international. It is not just in one hospital or community, but in hospitals and communities worldwide. Therefore, if we are going to curtail the problem we have to approach it on a global scale.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. S.B. Levy. Starting Life Resistance-free. New Eng J Med. 323: 335–337 (1990).

    Article  PubMed  CAS  Google Scholar 

  2. S.B. Levy. “The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle.” Plenum Publishing Corp., New York (1992).

    Google Scholar 

  3. M.L. Cohen. Epidemiology of drug resistance: implications for a post antimicrobial era. Science. 257: 1050–1054 (1992).

    Article  PubMed  CAS  Google Scholar 

  4. H.C. Neu. The crisis in antibiotic resistance. Science. 257: 1064–1072 (1992).

    Article  PubMed  CAS  Google Scholar 

  5. S.B. Levy. Ecology of antibiotic resistance determinants. In: “Antibiotic Resistance Genes: Ecology, Transfer and Expression,” S.B. Levy and R.P. Novick, eds., Cold Spg. Harbor Press, New York pp. 17–29 (1986).

    Google Scholar 

  6. T. Akiba, L. Koyama, Y. Ishiki, S. Kimura, and T. Rukushima. On the mechanism of the development of multiple drug resistant clones of Shigella. Jap J Microbiol. 4: 219–227 (1960).

    PubMed  CAS  Google Scholar 

  7. M.F. DeFlaun and S.B. Levy. Genes and their varied hosts. In: “Gene Transfer in the Enviroment,” S.B. Levy and R.V. Miller eds., McGraw-Hill, New York (1989) p. 1–32.

    Google Scholar 

  8. L.W. Riley, E. Arathoon, and V.B. Loverde. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infection: a community-based study. Am Rev Respir Dis. 139: 1282–1285 (1989).

    Article  PubMed  CAS  Google Scholar 

  9. R. Munoz, T.J. Coffey, M. Daniels, C.G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J.M. Musser, B.G. Spratt, and A. Tomasz. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis. 164: 302–306 (1991).

    Article  PubMed  CAS  Google Scholar 

  10. S.B. Levy, G.B. FitzGerald, and A.B. Macone. Spread of antibiotic resistance plasmids from chicken to chicken and from chicken to man. Nature. 260: 40–42 (1976).

    Article  PubMed  CAS  Google Scholar 

  11. R. Rolland, G. Hausfater, B. Marshall, and S.B. Levy. Increased frequency of antibiotic resistant gut flora in wild baboons in contact with human refuse. Appl. Environ. Microbiol. 49: 791–794 (1985).

    CAS  Google Scholar 

  12. B.R. Bloom and C.J.L. Murray. Tuberculosis: commentary on a re-emergent killer. Science. 257: 1055–1063 (1992).

    Article  PubMed  CAS  Google Scholar 

  13. K.L. Deuchars, K.L. and V. Ling. P-glycoprotein and multidrug resistance in cancer chemotherapy. Sem Oncol. 16: 156–165 (1989).

    CAS  Google Scholar 

  14. T. Watanabe. Infectious heredity of multiple drug resistance in bacteria. Bacteriol Rev. 27: 87–115 (1963).

    PubMed  CAS  Google Scholar 

  15. J.A. Frost, G.A. Willshaw, E.A. Barclay, B. Rowe, P. Lemmens, and J. Vandepitte. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa. J Hyg. 94: 163–72 (1985).

    Article  PubMed  CAS  Google Scholar 

  16. A. Fenoll, C.M. Bourgon, R. Munoz, D. Viciosi, and J. Casai. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979–1989. Rev Inf Dis. 13: 56–60 (1991).

    Article  CAS  Google Scholar 

  17. P.C. Applebaum. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 15: 77–83 (1992).

    Article  Google Scholar 

  18. S. Block, J. Hedrich, P. Wright et al. Drug resistant Streptococcus pneumoniae Kentucky and Tennessee, 1993. Morb Mortal Weekly Rep. 43: 23–25 (1993).

    Google Scholar 

  19. P. Geslin, A. Fremaux, and G. Sissia. Situation actuelle de la resistance des pneumocoques aux antibiotiques en France: bilan du Centre national de reference Lett del’Infect. 7: 477–486 (1993).

    Google Scholar 

  20. M.M. Sloas, F.F. Barrett, P.J. Chesney, B.K. English, B.C. Hill, F.C. Tenover, and R.J. Leggiadro. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 11: 662–666 (1992).

    PubMed  CAS  Google Scholar 

  21. W.L. Nelson, D.L. Kennedy, C.S. Lao, and J.N. Kuritsky. Outpatient systemic antiinfective use by children in the United States, 1977–1986. Pediat Infect Dis J. 7: 505–509 (1988).

    Article  CAS  Google Scholar 

  22. K. Machka, I. Braveny, H. Dabernat, K. Dornbusch, E. Van Dyck, F.H. Kayser, B. Van Klingeren, H. Mittermayer, E. Perea, and M. Powell. Distribution and resistance patterns of Hemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis. 7: 14–24 (1988).

    Article  PubMed  CAS  Google Scholar 

  23. P.J. Collignon, J.M. Bell, S.J. Maclnnes, G.L. Gilbert, M. Toohey, and the Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother. 30: 153–163 (1992).

    Article  PubMed  CAS  Google Scholar 

  24. E. Obasecki-Ebor, S.M. Oyaides, and E.E. Okpere. Incidence of penicillinase producing Neiserria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria. Geniotourin Med 61: 367–70 (1985).

    Google Scholar 

  25. R.J. Gorwitz, A.K. Nakashima, and J.S. Moran. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae-United States, 1988–1991. Morbid Mortal Weekly Rep. 42: 29–36 (1993).

    CAS  Google Scholar 

  26. World Health Organization. Current treatments in the control of sexually transmitted diseases. WHO/VDT/83; 43: 1–45 (1986).

    Google Scholar 

  27. F. Baquero, J. Martinez-Beltran, and E. Loga. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 28:Suppl. 0 31–38 (1991).

    Article  CAS  Google Scholar 

  28. J. Piper, L. Steele-Moore, B. Schneider, and W. Holloway. Serious infections caused by relatively resistant viridans streptococci. Abst 1049 1993 ICAAC meeting, New Orleans ASM (1993).

    Google Scholar 

  29. T.R. Frieden, T. Sterling, A. Pablos-Mendez, J.O. Kilburn, G.M. Cauthen, and S.W. Dooley. The emergence of drug-resistant tuberculosis in New York City. New Eng J Med 328: 521–526 (1993).

    Article  PubMed  CAS  Google Scholar 

  30. S. Amidi, S. Solter, B. Rashidian, A.-R. Zokajan, and F. Razmjolan. Antibiotic use and abuse among physicians in private practice in Shiraz, Iran. Medical Care. 13: 341–345 (1975).

    Article  PubMed  CAS  Google Scholar 

  31. A. DePaola, P.A. Flynn, R.M. McPhearson, and S.B. Levy. Phenotypic and genotypic characterization of tetracycline and oxytetracycline resistant Aeromonas from cultured channel catfish (Ictalurus punctatus) and their environments. Appl Env Microb. 54: 1861–1863 (1988).

    CAS  Google Scholar 

  32. S.B. Levy, S.B. Antibiotic use for growth promotion in animals: ecologic and public health consequences. J Food Protection. 50: 616–620 (1987).

    Google Scholar 

  33. S.B. Levy, G.B. Fitzgerald. and A.B. Macone. Changes in intestinal flora of farm personnel after introduction of tetracycline-supplemented feed on a farm. New Eng. J. Med. 295: 583–588 (1976).

    Article  CAS  Google Scholar 

  34. J.K. Moller, A.L. Bak, A. Stenderup, H. Zachariae, and H. Afzelius. Changing patterns of plasmid-mediated resistance during tetracycline therapy. Antimicrob Agents Chemother. 11: 388–391 (1977).

    Article  PubMed  CAS  Google Scholar 

  35. W.E. Kloos. Effect of single antibiotic therapy on Staphylococcus community structure. APUA Newsletter. 5: 4: 1–2 (1987).

    Google Scholar 

  36. S.B. Levy. Antibiotic resistant bacteria in food of man and animals. In: “Antimicrobials and Agriculture,” M. Woodbine, ed., Butterworths, London (1984) pp. 525–531.

    Google Scholar 

  37. C.E. Phelps. Bug/Drug resistance. Medical Care. 27: 194–203 (1989).

    Article  PubMed  CAS  Google Scholar 

  38. S.D. Holmberg, S.L. Solomon, and P.A. Blake. Health and economic impacts of antimicrobial resistance. Rev Inf Dis. 9: 1065–1078 (1987).

    Article  CAS  Google Scholar 

  39. M.L. Nelson, B.H. Park, J.S. Andrews, V.A. Georgian, R.C. Thomas, and S.B. Levy. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5hydroxy-6-deoxy tetracyclines, J. Med.Chem. 36: 370–377 (1993).

    Article  PubMed  CAS  Google Scholar 

  40. G.N. Robinson. Evolution of b-lactamase inhibitors. Rev. Infect. Dis. 13, Suppl. 9 5727–32 (1991).

    Google Scholar 

  41. I. Chopra. The magainins: antimicrobial peptides with potential for topical application. J. Antimicr. Chemother. 32: 351–353 (1993).

    Article  CAS  Google Scholar 

  42. S.B. Levy. Antibiotic availability and use: consequences to man and his environment. J. Clinical Epidemiology. 44:S11: 83S - 87S (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center For Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts, USA

    Stuart B. Levy

Authors
  1. Stuart B. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

    Donald L. Jungkind

  2. St. Christopher’s Hospital for Children, Philadelphia, Pennsylvania, USA

    Joel E. Mortensen

  3. The Graduate Hospital, Philadelphia, Pennsylvania, USA

    Henry S. Fraimow

  4. Merck Research Laboratories, West Point, Pennsylvania, USA

    Gary B. Calandra

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Levy, S.B. (1995). Antimicrobial Resistance: A Global Perspective. In: Jungkind, D.L., Mortensen, J.E., Fraimow, H.S., Calandra, G.B. (eds) Antimicrobial Resistance. Advances in Experimental Medicine and Biology, vol 390. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9203-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9203-4_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9205-8

  • Online ISBN: 978-1-4757-9203-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation